Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Alpha Teknova Inc (OQ:TKNO)

Business Focus: Diagnostic & Testing Substances

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 2451 Bert Drive
HOLLISTER CA 95023
Tel: N/A
Website: https://www.teknova.com
IR: See website
Key People
Stephen Gunstream
President, Chief Executive Officer, Director
Matthew C. Lowell
Chief Financial Officer
Damon Terrill
Chief Compliance Officer, General Counsel
Business Overview
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
Financial Overview
For the three months ended 31 March 2024, Alpha Teknova Inc revenues increased 2% to $9.3M. Net loss decreased 8% to $8.1M. Revenues reflect Clinical Solutions segment increase of 7% to $1.7M, Other segment increase of 20% to $306K, United States segment increase of 2% to $8.9M, International segment increase of 6% to $420K. Lower net loss reflects Sales and marketing - Balancing value decrease of 28% to $1.6M (expense).